ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351866 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351866; 2) Community: the network communities that were significantly associated with the response to NSC 351866; 3) Molecule: the relationships between components within communities and NSC 351866; 4) MDR: the compounds that were significantly associated with the NSC 351866.

NSC Compound Enrichment Correlation
NSC 672136 9-.alpha.-Hydroxyparthenolide 0.0414190425892871 0.3163698
NSC 673502 (+)-6-Bromo-3-bromomethyl-2,3,7-trichloro-7-methyl-1-octene 0.0414190425892871 -0.14917559
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.0414190425892871 0.26483764
NSC 676348 Null 0.0414190425892871 0.23980754
NSC 678044 Null 0.0414190425892871 0.35874296
NSC 679716 1H-Pyrazole-3-carboxylic acid, 5-benzoyl-4,5-dihydro- 4-phenyl-, ethyl ester 0.0414190425892871 0.2237558
NSC 681635 Camptothecin Derivative 0.0414190425892871 0.17593519
NSC 681639 Camptothecin Derivative 0.0414190425892871 0.14315127
NSC 682400 (-)7,8-Dihydrocalanolide A 0.0414190425892871 0.29773056
NSC 688978 Perylene-4,9-dione, 5,8-dihydroxy-1,3,10,12-tetramethoxy- 6,7-dipropyl- 0.0414190425892871 0.32933372
Total:79  Current:64    [First] [Prev] [Next] [Last]